Total Payments
$9,182
2024 Payments
$1,307
Companies
36
Transactions
461
Medicare Patients
647
Medicare Billing
$53,592
Payment Breakdown by Category
Food & Beverage$9,043 (98.5%)
Education$138.69 (1.5%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $9,043 | 456 | 98.5% |
| Education | $138.69 | 5 | 1.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $1,307 | 67 | $0 (2024) |
| GlaxoSmithKline, LLC. | $1,056 | 62 | $0 (2024) |
| GENZYME CORPORATION | $919.43 | 36 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $668.94 | 26 | $0 (2023) |
| Novartis Pharmaceuticals Corporation | $487.84 | 25 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $445.52 | 29 | $0 (2022) |
| Genentech USA, Inc. | $432.33 | 25 | $0 (2024) |
| Shire North American Group Inc | $382.85 | 25 | $0 (2019) |
| Takeda Pharmaceuticals U.S.A., Inc. | $372.03 | 14 | $0 (2024) |
| CSL Behring | $308.79 | 18 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,307 | 52 | GENZYME CORPORATION ($207.89) |
| 2023 | $1,478 | 60 | GENZYME CORPORATION ($230.75) |
| 2022 | $1,436 | 69 | AstraZeneca Pharmaceuticals LP ($293.59) |
| 2021 | $360.98 | 19 | GlaxoSmithKline, LLC. ($68.26) |
| 2020 | $350.47 | 20 | CSL Behring ($58.52) |
| 2019 | $1,413 | 79 | GlaxoSmithKline, LLC. ($209.73) |
| 2018 | $1,523 | 78 | AstraZeneca Pharmaceuticals LP ($276.38) |
| 2017 | $1,314 | 84 | GlaxoSmithKline, LLC. ($311.28) |
All Payment Transactions
461 individual payment records from CMS Open Payments — Page 1 of 19
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/19/2024 | Genentech USA, Inc. | Xolair (Biological) | Food and Beverage | In-kind items and services | $30.86 | General |
| Category: Immunology | ||||||
| 11/14/2024 | Amgen Inc. | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $22.52 | General |
| Category: Inflammation | ||||||
| 11/12/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $16.78 | General |
| Category: Immunology | ||||||
| 11/07/2024 | Takeda Pharmaceuticals U.S.A., Inc. | CUVITRU (Biological) | Food and Beverage | In-kind items and services | $29.71 | General |
| Category: IMMUNOLOGY | ||||||
| 10/31/2024 | Lilly USA, LLC | EBGLYSS (Drug) | Food and Beverage | In-kind items and services | $23.12 | General |
| Category: Immunology | ||||||
| 10/30/2024 | Cycle Pharmaceuticals Inc | Sajazir (Drug) | Food and Beverage | In-kind items and services | $20.44 | General |
| Category: IMMUNOLOGY | ||||||
| 10/30/2024 | Cycle Pharmaceuticals Inc | Tascenso ODT (Drug) | Food and Beverage | In-kind items and services | $18.85 | General |
| Category: NEUROLOGY | ||||||
| 10/29/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $29.28 | General |
| Category: Respiratory | ||||||
| 10/24/2024 | Grifols USA, LLC | Xembify (Biological) | Food and Beverage | In-kind items and services | $16.93 | General |
| Category: Immunology and Neurology | ||||||
| 10/23/2024 | Amgen Inc. | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $23.38 | General |
| Category: Inflammation | ||||||
| 10/17/2024 | Pharming Healthcare, Inc. | RUCONEST (Biological) | Food and Beverage | In-kind items and services | $19.27 | General |
| Category: BIOLOGIC | ||||||
| 10/15/2024 | Novartis Pharmaceuticals Corporation | XOLAIR (Drug) | Food and Beverage | In-kind items and services | $25.90 | General |
| Category: Pulmonary/Respiratory Diseases | ||||||
| 10/08/2024 | Hikma Pharmaceuticals USA | Ryaltris (Drug) | Food and Beverage | In-kind items and services | $19.61 | General |
| Category: Pulmonary/Respiratory Diseases | ||||||
| 10/03/2024 | Pharming Healthcare, Inc. | RUCONEST (Biological) | Food and Beverage | In-kind items and services | $28.19 | General |
| Category: BIOLOGIC | ||||||
| 09/26/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $24.00 | General |
| Category: Dermatology | ||||||
| 09/25/2024 | Novartis Pharmaceuticals Corporation | XOLAIR (Drug) | Food and Beverage | In-kind items and services | $18.65 | General |
| Category: Pulmonary/Respiratory Diseases | ||||||
| 09/24/2024 | Takeda Pharmaceuticals U.S.A., Inc. | TAKHZYRO (Biological) | Food and Beverage | In-kind items and services | $17.71 | General |
| Category: GENETIC DISEASE | ||||||
| 09/19/2024 | Grifols USA, LLC | Xembify (Biological) | Food and Beverage | In-kind items and services | $22.88 | General |
| Category: Immunology and Neurology | ||||||
| 09/12/2024 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $19.17 | General |
| Category: Respiratory | ||||||
| 09/11/2024 | Novartis Pharmaceuticals Corporation | XOLAIR (Drug) | Food and Beverage | In-kind items and services | $20.04 | General |
| Category: Pulmonary/Respiratory Diseases | ||||||
| 08/29/2024 | kaleo, Inc. | AUVI-Q (Drug) | Food and Beverage | In-kind items and services | $33.56 | General |
| Category: Allergy | ||||||
| 08/27/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $17.63 | General |
| Category: IMMUNOLOGY | ||||||
| 08/15/2024 | Pharming Healthcare, Inc. | RUCONEST (Biological) | Food and Beverage | In-kind items and services | $28.55 | General |
| Category: BIOLOGIC | ||||||
| 07/26/2024 | kaleo, Inc. | AUVI-Q (Drug) | Food and Beverage | In-kind items and services | $15.56 | General |
| Category: Allergy | ||||||
| 07/12/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $27.78 | General |
| Category: Dermatology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 257 | 1,194 | $85,232 | $21,183 |
| 2022 | 8 | 248 | 984 | $78,621 | $19,569 |
| 2021 | 4 | 71 | 76 | $16,046 | $4,934 |
| 2020 | 4 | 71 | 374 | $16,410 | $7,907 |
Total Patients
647
Total Services
2,628
Medicare Billing
$53,592
Procedure Codes
25
All Medicare Procedures & Services
25 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 62 | 83 | $25,232 | $7,940 | 31.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 27 | 27 | $12,582 | $3,429 | 27.3% |
| 95004 | Test for allergy using allergenic extract | Office | 2023 | 27 | 917 | $17,423 | $2,864 | 16.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 30 | 33 | $6,798 | $2,394 | 35.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 12 | 12 | $4,860 | $1,715 | 35.3% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 17 | 17 | $5,202 | $1,618 | 31.1% |
| 94010 | Test to measure expiratory airflow and volume | Office | 2023 | 33 | 42 | $4,452 | $864.10 | 19.4% |
| 95012 | Test to measure the level of nitric oxide gas | Office | 2023 | 13 | 16 | $928.00 | $255.16 | 27.5% |
| 96160 | Administration and interpretation of patient-focused health risk assessment | Office | 2023 | 36 | 47 | $7,755 | $103.79 | 1.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 53 | 77 | $23,408 | $7,738 | 33.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 51 | 58 | $11,948 | $4,027 | 33.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 26 | 26 | $12,116 | $3,007 | 24.8% |
| 95004 | Test for allergy using allergenic extract | Office | 2022 | 20 | 714 | $13,566 | $2,464 | 18.2% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 15 | 15 | $4,590 | $943.55 | 20.6% |
| 94010 | Test to measure expiratory airflow and volume | Office | 2022 | 31 | 32 | $3,392 | $677.38 | 20.0% |
| 87426 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | Office | 2022 | 17 | 17 | $2,176 | $619.68 | 28.5% |
| 96160 | Administration and interpretation of patient-focused health risk assessment | Office | 2022 | 35 | 45 | $7,425 | $92.45 | 1.2% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 35 | 38 | $6,127 | $2,460 | 40.2% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 11 | 11 | $3,860 | $1,403 | 36.4% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 12 | 12 | $3,584 | $1,037 | 28.9% |
| 96160 | Administration and interpretation of patient-focused health risk assessment | Office | 2021 | 13 | 15 | $2,475 | $33.78 | 1.4% |
| 95165 | Preparation and provision of single or multiple antigens for allergen immunotherapy | Office | 2020 | 12 | 298 | $5,960 | $3,333 | 55.9% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 28 | 41 | $5,025 | $2,106 | 41.9% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 15 | 15 | $3,825 | $1,975 | 51.6% |
| 94010 | Measurement and graphic recording of total and timed exhaled air capacity | Office | 2020 | 16 | 20 | $1,600 | $493.58 | 30.8% |
About Dr. Sharon Seth, M.D
Dr. Sharon Seth, M.D is a Allergy & Immunology healthcare provider based in Sterling, Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/18/2010. The National Provider Identifier (NPI) number assigned to this provider is 1922329465.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Sharon Seth, M.D has received a total of $9,182 in payments from pharmaceutical and medical device companies, with $1,307 received in 2024. These payments were reported across 461 transactions from 36 companies. The most common payment nature is "Food and Beverage" ($9,043).
As a Medicare-enrolled provider, Seth has provided services to 647 Medicare beneficiaries, totaling 2,628 services with total Medicare billing of $53,592. Data is available for 4 years (2020–2023), covering 25 distinct procedure/service records.
Ad
Practice Information
- Specialty Allergy & Immunology
- Other Specialties Internal Medicine, Allergy & Immunology
- Location Sterling, VA
- Active Since 06/18/2010
- Last Updated 05/04/2024
- Taxonomy Code 207K00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1922329465
Products in Payments
- DUPIXENT (Biological) $1,065
- NUCALA (Biological) $698.60
- TEZSPIRE (Biological) $517.58
- Xolair (Biological) $353.66
- XOLAIR (Biological) $342.97
- DUPIXENT (Drug) $321.29
- FASENRA (Biological) $280.98
- EUCRISA (Drug) $270.48
- CUVITRU (Biological) $254.63
- RUCONEST (Biological) $241.90
- TAKHZYRO (Biological) $221.00
- QVAR (Drug) $219.96
- FASENRA (Drug) $211.89
- RINVOQ (Biological) $206.95
- DUPIXENT DUPILUMAB INJECTION (Biological) $188.68
- Hizentra (Biological) $179.92
- CUTAQUIG (Biological) $178.83
- TRELEGY ELLIPTA (Drug) $177.85
- OPZELURA (Drug) $175.64
- BEVESPI AEROSPHERE (Drug) $171.24
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.